Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína

Detalhes bibliográficos
Ano de defesa: 2023
Autor(a) principal: Medeiros, Kaline de Araújo lattes
Orientador(a): Damasceno, Bolívar Ponciano Goulart de Lima lattes
Banca de defesa: Lima, Ádley Antonini Neves de, Silva, Paulo César Dantas da, Rocha, Wilma Raianny Vieira da
Tipo de documento: Dissertação
Tipo de acesso: Acesso embargado
Idioma: por
Instituição de defesa: Universidade Estadual da Paraíba
Programa de Pós-Graduação: Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF
Departamento: Pró-Reitoria de Pós-Graduação e Pesquisa - PRPGP
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://tede.bc.uepb.edu.br/jspui/handle/tede/4518
Resumo: Papain (PAP) is an enzyme that has several pharmacological activities such as healing, antimicrobial and anti-inflammatory properties. However, it has low stability, which is a problem for the development of therapeutic formulations. In view of this, a strategy to overcome this adversity is to perform immobilization through the PAP adsorption technique on substrates, for example, laponite® (LAP). Thus, the objective of this work was to develop and characterize a nanostructured hybrid system (SHN) composed of LAP and PAP. For this, the experimental conditions of adsorption of this enzyme in LAP were evaluated, considering the effect of pH, initial concentration of PAP and contact time. Equilibrium and kinetic studies were carried out within the range of pH 5.0 to 7.0, with reaction times from 0 to 2880 min and with concentrations from 4.500 to 25.500 mg/L in sodium phosphate buffer, under stirring at 200 rpm. Langmuir, Freundlich and Temkin isothermal models were used, as well as pseudo-first order, pseudo-second order and Elovich kinetics. The SHN were characterized by Fourier transform infrared spectroscopy (FTIR), thermogravimetric and derivative analysis (TG and DTG), differential thermal analysis (DTA) and X-ray diffraction (XRD). The results showed that the interaction between PAP-LAP is influenced by pH, with maximum adsorption at pH 7, the isotherm study showed that the equilibrium conditions of PAP-LAP adsorption obey the Freundlich model. Adsorption kinetics showed a fast phase up to 60 min and a slow one from 120 to 2880 min, fitting the pseudo-second order model. The maximum amount of PAP adsorbed on the LAP was 1243.6 mg/g, obtained at a concentration of 15.500 mg/L, at pH 7, in a time of 2880 min. The intercalation of PAP in the LAP was verified by the FTIR and XRD patterns, since an increase in the interlamellar distance from 1.252 nm (LAP) to 1.315 nm (SHN) was seen, with SHN spectra showing smaller vibrations referring to the PAP in the LAP, when compared to the isolated spectra of the drug. The mass loss profile in relation to time, demonstrated from the results obtained from TG/DTG/DTA, highlighted that the greatest losses occurred at pH 7 and at the highest concentration of drug, which was the work standard chosen. Considering the results obtained, it can be concluded that the process of adsorption of PAP in LAP promotes the feasibility of obtaining a SHN, with the ability to overcome the low enzymatic stability. It was proved that the increase in the concentration of PAP and the pH of the medium caused an increase in adsorption, at pH 7 there is formation of a heterogeneous surface and the adsorption occurs in multilayer, which is related to the intercalation capacity of PAP in the LAP lamellae. It is possible to point out that the longer the contact time between the adsorbate and the adsorbent, the greater the adsorption capacity due to the exfoliation of the lamellae of this clay mineral, this process represents a viable alternative to remedy the industrial need for PAP immobilization.
id UEPB_da49398dc865d22d1c50c8d35f0cda55
oai_identifier_str oai:tede.bc.uepb.edu.br:tede/4518
network_acronym_str UEPB
network_name_str Biblioteca Digital de Teses e Dissertações da UEPB
repository_id_str
spelling Damasceno, Bolívar Ponciano Goulart de Limahttp://lattes.cnpq.br/6407334157973308Silva, Dayanne Tomaz Casimiro dahttp://lattes.cnpq.br/6515613697746626Lima, Ádley Antonini Neves deSilva, Paulo César Dantas daRocha, Wilma Raianny Vieira da12202338462http://lattes.cnpq.br/7090506973472469Medeiros, Kaline de Araújo2023-04-05T14:34:02Z2999-12-312023-01-10MEDEIROS, Kaline de Araújo. Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína. 2023. 67f. Dissertação (Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF) - Universidade Estadual da Paraíba, Campina Grande, 2023.http://tede.bc.uepb.edu.br/jspui/handle/tede/4518Papain (PAP) is an enzyme that has several pharmacological activities such as healing, antimicrobial and anti-inflammatory properties. However, it has low stability, which is a problem for the development of therapeutic formulations. In view of this, a strategy to overcome this adversity is to perform immobilization through the PAP adsorption technique on substrates, for example, laponite® (LAP). Thus, the objective of this work was to develop and characterize a nanostructured hybrid system (SHN) composed of LAP and PAP. For this, the experimental conditions of adsorption of this enzyme in LAP were evaluated, considering the effect of pH, initial concentration of PAP and contact time. Equilibrium and kinetic studies were carried out within the range of pH 5.0 to 7.0, with reaction times from 0 to 2880 min and with concentrations from 4.500 to 25.500 mg/L in sodium phosphate buffer, under stirring at 200 rpm. Langmuir, Freundlich and Temkin isothermal models were used, as well as pseudo-first order, pseudo-second order and Elovich kinetics. The SHN were characterized by Fourier transform infrared spectroscopy (FTIR), thermogravimetric and derivative analysis (TG and DTG), differential thermal analysis (DTA) and X-ray diffraction (XRD). The results showed that the interaction between PAP-LAP is influenced by pH, with maximum adsorption at pH 7, the isotherm study showed that the equilibrium conditions of PAP-LAP adsorption obey the Freundlich model. Adsorption kinetics showed a fast phase up to 60 min and a slow one from 120 to 2880 min, fitting the pseudo-second order model. The maximum amount of PAP adsorbed on the LAP was 1243.6 mg/g, obtained at a concentration of 15.500 mg/L, at pH 7, in a time of 2880 min. The intercalation of PAP in the LAP was verified by the FTIR and XRD patterns, since an increase in the interlamellar distance from 1.252 nm (LAP) to 1.315 nm (SHN) was seen, with SHN spectra showing smaller vibrations referring to the PAP in the LAP, when compared to the isolated spectra of the drug. The mass loss profile in relation to time, demonstrated from the results obtained from TG/DTG/DTA, highlighted that the greatest losses occurred at pH 7 and at the highest concentration of drug, which was the work standard chosen. Considering the results obtained, it can be concluded that the process of adsorption of PAP in LAP promotes the feasibility of obtaining a SHN, with the ability to overcome the low enzymatic stability. It was proved that the increase in the concentration of PAP and the pH of the medium caused an increase in adsorption, at pH 7 there is formation of a heterogeneous surface and the adsorption occurs in multilayer, which is related to the intercalation capacity of PAP in the LAP lamellae. It is possible to point out that the longer the contact time between the adsorbate and the adsorbent, the greater the adsorption capacity due to the exfoliation of the lamellae of this clay mineral, this process represents a viable alternative to remedy the industrial need for PAP immobilization.A papaína (PAP) é uma enzima que possui várias atividades farmacológicas como propriedade cicatrizante, antimicrobiana e anti-inflamatória. Porém, apresenta baixa estabilidade, o que é um problema para o desenvolvimento de formulações terapêuticas. Diante disso, uma estratégia para contornar essa adversidade é a execução da imobilização através da técnica de adsorção da PAP em substratos, por exemplo, a laponita® (LAP). Assim, o objetivo desse trabalho foi desenvolver e caracterizar um sistema híbrido nanoestruturado (SHN) composto de LAP e PAP. Para isso foram avaliadas as condições experimentais de adsorção dessa enzima na LAP, considerando o efeito do pH, da concentração inicial da PAP e do tempo de contato. Os estudos de equilíbrio e de cinética foram realizados dentro da faixa de pH 5,0 a 7,0, com tempos de reação de 0 a 2880 min e com concentrações de 4.500 a 25.500 mg/L em tampão fosfato de sódio, sob agitação a 200 rpm. Foram utilizados os modelos isotérmicos de Langmuir, Freundlich e Temkin, e os cinéticos de pseudo-primeira ordem, pseudo-segunda ordem e Elovich. Os SHN foram caracterizados pelas técnicas de espectroscopia de infravermelho por transformada de Fourier (FTIR), análise termogravimétrica e derivada (TG e DTG), análise térmica diferencial (DTA) e difração de raio-X (DRX). Os resultados apontaram que a interação entre PAP-LAP é influenciada pelo pH, detendo de máxima adsorção em pH 7, o estudo de isoterma evidenciou que as condições de equilíbrio da adsorção de PAP-LAP obedecem ao modelo de Freundlich. A cinética de adsorção apresentou uma fase rápida até 60 min e uma lenta de 120 a 2880 min, ajustando-se ao modelo de pseudo-segunda ordem. A quantidade máxima de PAP adsorvida na LAP foi de 1243,6 mg/g, obtida na concentração de 15.500 mg/L, em pH 7, no tempo de 2880 min. A intercalação da PAP na LAP foi constatada pelos padrões de FTIR e DRX, uma vez que foi visto uma elevação na distância interlamelar de 1,252 nm (LAP) para 1,315 nm (SHN), com espectros dos SHN mostrando vibrações menores referentes à PAP na LAP, quando confrontado aos espectros isolados do fármaco. O perfil de perda de massa em relação ao tempo, demonstrado a partir dos resultados obtidos do TG/DTG/DTA, salientaram que as maiores perdas ocorreram no pH 7 e na maior concentração de fármaco, que foi o padrão de trabalho escolhido. Considerando os resultados obtidos, pode-se concluir que o processo de adsorção de PAP em LAP promove viabilidade de obtenção de um SHN, com capacidade de contornar a baixa estabilidade enzimática. Foi provado que a elevação da concentração da PAP e do pH do meio provocaram aumento da adsorção, em pH 7 há formação de uma superfície heterogênea e a adsorção ocorre em multicamada, o que está relacionado a capacidade de intercalação da PAP nas lamelas de LAP. É possível ressaltar que quanto maior o tempo de contato entre o adsorvato e o adsorvente, maior a capacidade de adsorção devido a esfoliação das lamelas deste argilomineral, esse processo representa uma alternativa viável para sanar a necessidade industrial de imobilização da PAP.Submitted by kalinearaujo9197@hotmail.com (kalinearaujo9197@hotmail.com) on 2023-02-25T23:54:50Z No. of bitstreams: 2 DS - Kaline de Araújo Medeiros.pdf: 1860385 bytes, checksum: bc8068ea9d72a5f460791ada82b2514d (MD5) Termo de Depósito BDTD - Kaline de Araújo Medeiros .pdf: 76173 bytes, checksum: d25421002aedb89a0ecdf90ac9d568d3 (MD5)Approved for entry into archive by Jean Medeiros (jeanletras@uepb.edu.br) on 2023-02-27T17:30:25Z (GMT) No. of bitstreams: 2 DS - Kaline de Araújo Medeiros.pdf: 1860385 bytes, checksum: bc8068ea9d72a5f460791ada82b2514d (MD5) Termo de Depósito BDTD - Kaline de Araújo Medeiros .pdf: 76173 bytes, checksum: d25421002aedb89a0ecdf90ac9d568d3 (MD5)Made available in DSpace on 2023-04-05T14:34:02Z (GMT). No. of bitstreams: 2 DS - Kaline de Araújo Medeiros.pdf: 1860385 bytes, checksum: bc8068ea9d72a5f460791ada82b2514d (MD5) Termo de Depósito BDTD - Kaline de Araújo Medeiros .pdf: 76173 bytes, checksum: d25421002aedb89a0ecdf90ac9d568d3 (MD5) Previous issue date: 2023-01-10Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESPapplication/pdfhttp://tede.bc.uepb.edu.br/jspui/retrieve/19238/DS%20-%20Kaline%20de%20Ara%c3%bajo%20Medeiros.pdf.jpghttp://tede.bc.uepb.edu.br/jspui/retrieve/19240/Termo%20de%20Dep%c3%b3sito%20BDTD%20-%20Kaline%20de%20Ara%c3%bajo%20Medeiros%20.pdf.jpgporUniversidade Estadual da ParaíbaPrograma de Pós-Graduação em Ciências Farmacêuticas - PPGCFUEPBBrasilPró-Reitoria de Pós-Graduação e Pesquisa - PRPGPPapaínaArgilomineraisPreparações farmacêuticasPharmaceutical preparationsClay mineralsPapainCIENCIAS DA SAUDE::FARMACIAFARMACIA::FARMACOTECNIAFARMACIA::ANALISE E CONTROLE E MEDICAMENTOSDesenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaínainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis81579685552518768746006006006006005248714503811102786997636413449754996-14982343668389320196216025074656932336info:eu-repo/semantics/embargoedAccessreponame:Biblioteca Digital de Teses e Dissertações da UEPBinstname:Universidade Estadual da Paraíba (UEPB)instacron:UEPBTHUMBNAILDS - Kaline de Araújo Medeiros.pdf.jpgDS - Kaline de Araújo Medeiros.pdf.jpgimage/jpeg3538http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/5/DS+-+Kaline+de+Ara%C3%BAjo+Medeiros.pdf.jpg69c0a1dd655563c1c41ababbc2275226MD55Termo de Depósito BDTD - Kaline de Araújo Medeiros .pdf.jpgTermo de Depósito BDTD - Kaline de Araújo Medeiros .pdf.jpgimage/jpeg6281http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/7/Termo+de+Dep%C3%B3sito+BDTD+-+Kaline+de+Ara%C3%BAjo+Medeiros+.pdf.jpg851eca856d4867e452c8b9f22d3ebf60MD57TEXTDS - Kaline de Araújo Medeiros.pdf.txtDS - Kaline de Araújo Medeiros.pdf.txttext/plain125790http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/4/DS+-+Kaline+de+Ara%C3%BAjo+Medeiros.pdf.txt989461df81ec56042e4d715c9f21a8e8MD54Termo de Depósito BDTD - Kaline de Araújo Medeiros .pdf.txtTermo de Depósito BDTD - Kaline de Araújo Medeiros .pdf.txttext/plain4368http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/6/Termo+de+Dep%C3%B3sito+BDTD+-+Kaline+de+Ara%C3%BAjo+Medeiros+.pdf.txt8ae16fdcbf1651991ff6734b4d0fd3b2MD56ORIGINALDS - Kaline de Araújo Medeiros.pdfDS - Kaline de Araújo Medeiros.pdfapplication/pdf1860385http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/2/DS+-+Kaline+de+Ara%C3%BAjo+Medeiros.pdfbc8068ea9d72a5f460791ada82b2514dMD52Termo de Depósito BDTD - Kaline de Araújo Medeiros .pdfTermo de Depósito BDTD - Kaline de Araújo Medeiros .pdfapplication/pdf76173http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/3/Termo+de+Dep%C3%B3sito+BDTD+-+Kaline+de+Ara%C3%BAjo+Medeiros+.pdfd25421002aedb89a0ecdf90ac9d568d3MD53LICENSElicense.txtlicense.txttext/plain; charset=utf-81960http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/1/license.txt6052ae61e77222b2086e666b7ae213ceMD51tede/45182023-04-06 01:06:40.467oai:tede.bc.uepb.edu.br: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Biblioteca Digital de Teses e Dissertaçõeshttp://tede.bc.uepb.edu.br/jspui/PUBhttp://tede.bc.uepb.edu.br/oai/requestbc@uepb.edu.br||opendoar:2023-04-06T04:06:40Biblioteca Digital de Teses e Dissertações da UEPB - Universidade Estadual da Paraíba (UEPB)false
dc.title.por.fl_str_mv Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína
title Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína
spellingShingle Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína
Medeiros, Kaline de Araújo
Papaína
Argilominerais
Preparações farmacêuticas
Pharmaceutical preparations
Clay minerals
Papain
CIENCIAS DA SAUDE::FARMACIA
FARMACIA::FARMACOTECNIA
FARMACIA::ANALISE E CONTROLE E MEDICAMENTOS
title_short Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína
title_full Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína
title_fullStr Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína
title_full_unstemmed Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína
title_sort Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína
author Medeiros, Kaline de Araújo
author_facet Medeiros, Kaline de Araújo
author_role author
dc.contributor.advisor1.fl_str_mv Damasceno, Bolívar Ponciano Goulart de Lima
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/6407334157973308
dc.contributor.advisor-co1.fl_str_mv Silva, Dayanne Tomaz Casimiro da
dc.contributor.advisor-co1Lattes.fl_str_mv http://lattes.cnpq.br/6515613697746626
dc.contributor.referee1.fl_str_mv Lima, Ádley Antonini Neves de
dc.contributor.referee2.fl_str_mv Silva, Paulo César Dantas da
dc.contributor.referee3.fl_str_mv Rocha, Wilma Raianny Vieira da
dc.contributor.authorID.fl_str_mv 12202338462
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/7090506973472469
dc.contributor.author.fl_str_mv Medeiros, Kaline de Araújo
contributor_str_mv Damasceno, Bolívar Ponciano Goulart de Lima
Silva, Dayanne Tomaz Casimiro da
Lima, Ádley Antonini Neves de
Silva, Paulo César Dantas da
Rocha, Wilma Raianny Vieira da
dc.subject.por.fl_str_mv Papaína
Argilominerais
Preparações farmacêuticas
topic Papaína
Argilominerais
Preparações farmacêuticas
Pharmaceutical preparations
Clay minerals
Papain
CIENCIAS DA SAUDE::FARMACIA
FARMACIA::FARMACOTECNIA
FARMACIA::ANALISE E CONTROLE E MEDICAMENTOS
dc.subject.eng.fl_str_mv Pharmaceutical preparations
Clay minerals
Papain
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::FARMACIA
FARMACIA::FARMACOTECNIA
FARMACIA::ANALISE E CONTROLE E MEDICAMENTOS
description Papain (PAP) is an enzyme that has several pharmacological activities such as healing, antimicrobial and anti-inflammatory properties. However, it has low stability, which is a problem for the development of therapeutic formulations. In view of this, a strategy to overcome this adversity is to perform immobilization through the PAP adsorption technique on substrates, for example, laponite® (LAP). Thus, the objective of this work was to develop and characterize a nanostructured hybrid system (SHN) composed of LAP and PAP. For this, the experimental conditions of adsorption of this enzyme in LAP were evaluated, considering the effect of pH, initial concentration of PAP and contact time. Equilibrium and kinetic studies were carried out within the range of pH 5.0 to 7.0, with reaction times from 0 to 2880 min and with concentrations from 4.500 to 25.500 mg/L in sodium phosphate buffer, under stirring at 200 rpm. Langmuir, Freundlich and Temkin isothermal models were used, as well as pseudo-first order, pseudo-second order and Elovich kinetics. The SHN were characterized by Fourier transform infrared spectroscopy (FTIR), thermogravimetric and derivative analysis (TG and DTG), differential thermal analysis (DTA) and X-ray diffraction (XRD). The results showed that the interaction between PAP-LAP is influenced by pH, with maximum adsorption at pH 7, the isotherm study showed that the equilibrium conditions of PAP-LAP adsorption obey the Freundlich model. Adsorption kinetics showed a fast phase up to 60 min and a slow one from 120 to 2880 min, fitting the pseudo-second order model. The maximum amount of PAP adsorbed on the LAP was 1243.6 mg/g, obtained at a concentration of 15.500 mg/L, at pH 7, in a time of 2880 min. The intercalation of PAP in the LAP was verified by the FTIR and XRD patterns, since an increase in the interlamellar distance from 1.252 nm (LAP) to 1.315 nm (SHN) was seen, with SHN spectra showing smaller vibrations referring to the PAP in the LAP, when compared to the isolated spectra of the drug. The mass loss profile in relation to time, demonstrated from the results obtained from TG/DTG/DTA, highlighted that the greatest losses occurred at pH 7 and at the highest concentration of drug, which was the work standard chosen. Considering the results obtained, it can be concluded that the process of adsorption of PAP in LAP promotes the feasibility of obtaining a SHN, with the ability to overcome the low enzymatic stability. It was proved that the increase in the concentration of PAP and the pH of the medium caused an increase in adsorption, at pH 7 there is formation of a heterogeneous surface and the adsorption occurs in multilayer, which is related to the intercalation capacity of PAP in the LAP lamellae. It is possible to point out that the longer the contact time between the adsorbate and the adsorbent, the greater the adsorption capacity due to the exfoliation of the lamellae of this clay mineral, this process represents a viable alternative to remedy the industrial need for PAP immobilization.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-04-05T14:34:02Z
dc.date.issued.fl_str_mv 2023-01-10
dc.date.available.fl_str_mv 2999-12-31
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv MEDEIROS, Kaline de Araújo. Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína. 2023. 67f. Dissertação (Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF) - Universidade Estadual da Paraíba, Campina Grande, 2023.
dc.identifier.uri.fl_str_mv http://tede.bc.uepb.edu.br/jspui/handle/tede/4518
identifier_str_mv MEDEIROS, Kaline de Araújo. Desenvolvimento de um sistema híbrido nanoestruturado de Laponita® e Papaína. 2023. 67f. Dissertação (Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF) - Universidade Estadual da Paraíba, Campina Grande, 2023.
url http://tede.bc.uepb.edu.br/jspui/handle/tede/4518
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv 8157968555251876874
dc.relation.confidence.fl_str_mv 600
600
600
600
600
dc.relation.department.fl_str_mv 524871450381110278
dc.relation.cnpq.fl_str_mv 6997636413449754996
-1498234366838932019
6216025074656932336
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Estadual da Paraíba
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF
dc.publisher.initials.fl_str_mv UEPB
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Pró-Reitoria de Pós-Graduação e Pesquisa - PRPGP
publisher.none.fl_str_mv Universidade Estadual da Paraíba
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UEPB
instname:Universidade Estadual da Paraíba (UEPB)
instacron:UEPB
instname_str Universidade Estadual da Paraíba (UEPB)
instacron_str UEPB
institution UEPB
reponame_str Biblioteca Digital de Teses e Dissertações da UEPB
collection Biblioteca Digital de Teses e Dissertações da UEPB
bitstream.url.fl_str_mv http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/5/DS+-+Kaline+de+Ara%C3%BAjo+Medeiros.pdf.jpg
http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/7/Termo+de+Dep%C3%B3sito+BDTD+-+Kaline+de+Ara%C3%BAjo+Medeiros+.pdf.jpg
http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/4/DS+-+Kaline+de+Ara%C3%BAjo+Medeiros.pdf.txt
http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/6/Termo+de+Dep%C3%B3sito+BDTD+-+Kaline+de+Ara%C3%BAjo+Medeiros+.pdf.txt
http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/2/DS+-+Kaline+de+Ara%C3%BAjo+Medeiros.pdf
http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/3/Termo+de+Dep%C3%B3sito+BDTD+-+Kaline+de+Ara%C3%BAjo+Medeiros+.pdf
http://tede.bc.uepb.edu.br/jspui/bitstream/tede/4518/1/license.txt
bitstream.checksum.fl_str_mv 69c0a1dd655563c1c41ababbc2275226
851eca856d4867e452c8b9f22d3ebf60
989461df81ec56042e4d715c9f21a8e8
8ae16fdcbf1651991ff6734b4d0fd3b2
bc8068ea9d72a5f460791ada82b2514d
d25421002aedb89a0ecdf90ac9d568d3
6052ae61e77222b2086e666b7ae213ce
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da UEPB - Universidade Estadual da Paraíba (UEPB)
repository.mail.fl_str_mv bc@uepb.edu.br||
_version_ 1797038572466864128